AT1001
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AT1001, covering 2018-09-07 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: AT1001 for the Treatment of Long COVID [Phase 2]